Works matching IS 02780232 AND DT 2020 AND VI 38 AND IP 3

Results: 26
    1
    2
    3
    4
    5

    Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data.

    Published in:
    2020
    By:
    • Palandri, Francesca;
    • Breccia, Massimo;
    • Tiribelli, Mario;
    • Bonifacio, Massimiliano;
    • Benevolo, Giulia;
    • Iurlo, Alessandra;
    • Elli, Elena M.;
    • Binotto, Gianni;
    • Tieghi, Alessia;
    • Polverelli, Nicola;
    • Martino, Bruno;
    • Abruzzese, Elisabetta;
    • Bergamaschi, Micaela;
    • Heidel, Florian H.;
    • Cavazzini, Francesco;
    • Crugnola, Monica;
    • Bosi, Costanza;
    • Isidori, Alessandro;
    • Auteri, Giuseppe;
    • Forte, Dorian
    Publication type:
    journal article
    6

    Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation.

    Published in:
    2020
    By:
    • Ferreri, Andrés J. M.;
    • Sassone, Marianna;
    • Angelillo, Piera;
    • Zaja, Francesco;
    • Re, Alessandro;
    • Di Rocco, Alice;
    • Spina, Michele;
    • Fabbri, Alberto;
    • Stelitano, Caterina;
    • Frezzato, Maurizio;
    • Volpetti, Stefano;
    • Zambello, Renato;
    • Rusconi, Chiara;
    • De Lorenzo, Daniela;
    • Scarano, Eloise;
    • Arcari, Annalisa;
    • Bertoldero, Giovanni;
    • Nonis, Alessandro;
    • Calimeri, Teresa;
    • Perrone, Salvatore
    Publication type:
    journal article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Real world outcomes with Bortezomib Thalidomide dexamethasone and Cyclophosphamide Bortezomib dexamethasone induction treatment for transplant eligible multiple myeloma patients in a Latin American country. A Retrospective Cohort Study from Grupo Argentino de Mieloma Múltiple.

    Published in:
    2020
    By:
    • Schütz, Natalia P.;
    • Ochoa, Paola;
    • Duarte, Patricio;
    • Remaggi, Guillermina;
    • Yantorno, Sebastián;
    • Corzo, Ariel;
    • Zabaljauregui, Soledad;
    • Shanley, Claudia;
    • Lopresti, Sergio;
    • Orlando, Sergio;
    • Verri, Verónica;
    • Quiroga, Luis;
    • García, Carlos A.;
    • Fernández, Vanesa;
    • Fantl, Dorotea
    Publication type:
    journal article
    18
    19
    20
    21
    22
    23

    The landscape of BCR-ABL mutations in patients with Philadelphia chromosome-positive leukaemias in the era of second-generation tyrosine kinase inhibitors.

    Published in:
    2020
    By:
    • Chien, Sheng‐Hsuan;
    • Liu, Hsueng‐Mei;
    • Chen, Po‐Ming;
    • Ko, Po‐Shen;
    • Lin, Jeong‐Shi;
    • Chen, Ying‐Ju;
    • Lee, Li‐Hsuan;
    • Hsiao, Liang‐Tsai;
    • Chiou, Tzeon‐Jye;
    • Gau, Jyh‐Pyng;
    • Yang, Muh‐Hwa;
    • Liu, Chun‐Yu;
    • Chien, Sheng-Hsuan;
    • Liu, Hsueng-Mei;
    • Chen, Po-Ming;
    • Ko, Po-Shen;
    • Lin, Jeong-Shi;
    • Chen, Ying-Ju;
    • Lee, Li-Hsuan;
    • Hsiao, Liang-Tsai
    Publication type:
    journal article
    24
    25

    Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial.

    Published in:
    2020
    By:
    • Schmitz, Christine;
    • Rekowski, Jan;
    • Müller, Stefan P.;
    • Hertenstein, Bernd;
    • Franzius, Christiane;
    • Ganser, Arnold;
    • Bengel, Frank M.;
    • Kroschinsky, Frank;
    • Kotzerke, Jörg;
    • La Rosée, Paul;
    • Freesmeyer, Martin;
    • Hoeffkes, Heinz‐Gert;
    • Hertel, Andreas;
    • Behringer, Dirk;
    • Mesters, Rolf;
    • Weckesser, Matthias;
    • Mahlmann, Stefan;
    • Haberkorn, Uwe;
    • Martens, Uwe;
    • Prange‐Krex, Gabriele
    Publication type:
    journal article
    26

    Issue Information.

    Published in:
    Hematological Oncology, 2020, v. 38, n. 3, p. 211, doi. 10.1002/hon.2642
    Publication type:
    Article